COMPLETE, FAST, NONINVASIVE ADVANCED WOUND CARE MANAGEMENT, PAIN RELIEF & QUALITY OF LIFE IMPROVEMENT
Products on this website for prescription (Rx) for U.S. residents only.
WHAT IS A CHRONIC WOUND?
According to WoundCareCenters.org, a chronic wound is one that has failed to progress through the phases of healing in an orderly and timely fashion and has shown no significant progress toward healing in 30 days. Chronic wounds can be effectively treated by advanced wound therapy or advanced wound management.
0
MAJOR DETRIMENTAL SIDE EFFECTS
97%
BLOOD CIRCULATION IMPROVEMENT
24
SUCCESSFUL MUMAN CLINICAL TRIALS
500,000+
SUCCESSFUL APPLICATIONS
COMPLETE, FAST, NONINVASIVE, ADVANCED WOUND CARE TREATMENTS IMPROVING QUALITY OF LIFE
When seeking advanced wound care treatments regularly, D’OXYVA® (deoxyhemoglobin vasodilator) improves microcirculation and promotes the blood flow in the smallest blood vessels to deliver important nutrients and oxygen to organs and cells, which in turn supports the body’s own self-healing powers, enabling you to be active again.
Clinical studies with D’OXYVA have shown extraordinary results for the role of transdermal noninvasive and advanced wound therapy using ultra-purified, nontoxic, FDA-cleared molecules, such as CO2, especially when all other approaches failed.
In an ongoing multiyear, multi-country, multicenter, randomized clinical trial on patients with diabetic foot ulcers, D’OXYVA has demonstrated speeding up diabetic wound healing and ultimately wound closure to an average of 5 weeks though advanced wound management**.
DID YOU KNOW?
Carbon can hold on to things and let them go, kind of like Velcro (which is made of carbon, as it happens). It makes strong bonds that give molecules such as proteins and drugs their shape, and also readily releases those bonds, letting molecules emit stored energy. (Think bombs and carbs.) And carbon’s ability to maintain four bonds at once makes it the periodic table’s architectural workhorse.
FAQs
NEED HELP AFFORDING D’OXYVA?
The D’OXYVA device is a simple, commercially-available device to deliver transdermal carbon dioxide (CO2 ). Read More >>
D’OXYVA®
(deoxyhemoglobin vasodilator)
medical carbon dioxide pressurized mini gas cartridges
(pronounced: DOX-y-va)
Circularity Healthcare operates a state-of-the-art supply chain and quality management system (QMS) for manufacturing. Read More >>
Under Circularity’s Center of Excellence (COE) and Center of Profit (COP) programs, we provide short-, and long-term equipment finance with zero interest and/or complete complimentary marketing support and training for private clinics, even in combination with third party therapies and diagnostics.*
We finance your equipment and finance, design and implement your marketing campaigns so you’ll attract more new customers and treat more patients more affordably and faster than ever before.
Circularity’s financing programs were designed for all kinds of situations and equipment and harness the speed and accuracy of the latest fintech. Circularity provides unmatched convenience and industry-leading support to our customers nationwide and internationally. Read More >>
FAQs
NEED HELP AFFORDING D’OXYVA?
The D’OXYVA device is a simple, commercially-available device to deliver transdermal carbon dioxide (CO2 ). Read More >>
D’OXYVA®
(deoxyhemoglobin vasodilator)
medical carbon dioxide pressurized mini gas cartridges
(pronounced: DOX-y-va)
Circularity Healthcare operates a state-of-the-art supply chain and quality management system (QMS) for manufacturing. Read More>>
Under Circularity’s Center of Excellence (COE) and Center of Profit (COP) programs, we provide short-, and long-term equipment finance with zero interest and/or complete complimentary marketing support and training for private clinics, even in combination with third party therapies and diagnostics.*
We finance your equipment and finance, design and implement your marketing campaigns so you’ll attract more new customers and treat more patients more affordably and faster than ever before.
Circularity’s financing programs were designed for all kinds of situations and equipment and harness the speed and accuracy of the latest fintech. Circularity provides unmatched convenience and industry-leading support to our customers nationwide and internationally. Read More >>
Latest Posts
Innovative Collaboration: The Cutting Edge of Medicine Goes “Behind The Scenes”
LOS ANGELES (PRWEB) DECEMBER 11, 2019 Circularity is partnering with Telly Award-Winning “Behind the Scenes” to provide regular, ongoing, high-quality content from leading experts in a variety of fields with an
What You Need to Know About Non-Healing Wounds
Chronic wounds are wounds that do not heal in a normal amount of time. This delay in healing can be due to a number of factors. Read on to learn
US health care system causing widespread burnout among doctors, nurses, report finds
The American health care system is so broken that it’s causing a growing epidemic of burnout among doctors and nurses. That’s according to a new 312-page report published by the
World-Famous Institute in Miami Has Reopened as ReLife Miami Institute Under the New Leadership of Famed Neurosurgeon Dr. Gelbard, Funding Led by Circularity Healthcare
The World Famous Institute in Miami, which specialized in cosmetic and plastic surgery as well as anti-aging and wellness treatments and catered to such famous celebrities as Kim Kardashian, has
Defects in Microcirculation and the Effect on Wound Healing: New Non-Invasive Treatments
The effects of defects in and poor functioning of the microcirculation on wound healing, especially in diabetic patients, can be devastating and life changing. As one particular example, Joseph L
Circularity Healthcare Negotiating $100 million Institutional Funding, Expands Successful D’OXYVA Phase 3 Diabetic Foot Ulcer Treatment Clinical Trials, Expects Fast-Track FDA Approval
Read Article in PRWeb [Los Angeles, CA, July 16, 2019] Circularity Healthcare LLC, developer and manufacturer of transdermal drug delivery and wound healing products, has announced that the company has entered
